Abstract

Breast cancer (BC) is the most frequent tumour affecting women all over the world. In low- and middle-income countries, where its incidence is expected to rise further, BC seems set to become a public health emergency. The aim of the present study is to provide a systematic review of current BC screening programmes in WHO European Region to identify possible patterns. Multiple correspondence analysis was performed to evaluate the association among: measures of occurrence; GNI level; type of BC screening programme; organization of public information and awareness campaigns regarding primary prevention of modifiable risk factors; type of BC screening services; year of screening institution; screening coverage and data quality. A key difference between High Income (HI) and Low and Middle Income (LMI) States, emerging from the present data, is that in the former screening programmes are well organized, with approved screening centres, the presence of mobile units to increase coverage, the offer of screening tests free of charge; the fairly high quality of occurrence data based on high-quality sources, and the adoption of accurate methods to estimate incidence and mortality. In conclusion, the governments of LMI countries should allocate sufficient resources to increase screening participation and they should improve the accuracy of incidence and mortality rates.

Highlights

  • Breast cancer (BC) is the most frequent tumour affecting women all over the world, with an incidence rate of 43.1, a mortality rate of 12.9, and a 5-year prevalence of 239.9 [1]

  • The governments of Low and Middle Income (LMI) countries should allocate sufficient resources to increase screening participation and they should improve the accuracy of incidence and mortality rates

  • The aim of the present study is to provide a systematic review of current BC screening programmes in WHO European Region countries to identify possible differences among countries based on gross national income (GNI) [26]

Read more

Summary

Introduction

Breast cancer (BC) is the most frequent tumour affecting women all over the world, with an incidence rate of 43.1 (per 100,000 ASR-W), a mortality rate of 12.9 (per 100,000 ASR-W), and a 5-year prevalence of 239.9 [1]. In low- and middle-income countries, where its incidence is expected to rise further, BC seems set to become a public health emergency [2], while the highest incidence rates, reported in high-income countries, are partially to be attributed to earlier screening detection [3]. (per 100,000 ASR-W) and mortality 16.0 (per 100,000 ASR-W). In EU-28 countries the incidence rate is. 80.3 (per 100,000 ASR-W) and the mortality rate 14.4 (per 100.000 ASR-W) [1]. Public Health 2017, 14, 452; doi:10.3390/ijerph14040452 www.mdpi.com/journal/ijerph

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.